Moreover, high CXCL2 level was associated with better first progression (P = .014, HR = 0.78, Fig. 3B) and post progression survival (P = 3.2e-6, HR = 0.59, Fig. 3C) in STAD. Here, CXCL2 is linked to gastric adenocarcinoma.